Boston Scientific Corporation
BSX NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 29, 2026
ET
EPS Est.
0.84
EPS Actual
0.86
Revenue Est.
$5.38B
Revenue Actual
$5.44B
Next Earnings Report
Date
Oct 28, 2026 · Wed
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.80
Revenue Est.
$5.26B
Company Overview
Boston Scientific Corporation (ticker BSX) is listed on NYSE with a market cap of about $74.87B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), Pre-market, with consensus EPS of 0.80. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 1, 2023 → Jul 29, 2026
Feb 1, 2023Range: 0.45 ~ 0.86Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 0.84 | 0.86 | $5.38B | $5.44B |
| Apr 22, 2026 | -- | 0.79 | 0.80 | $5.17B | $5.2B |
| Feb 4, 2026 | -- | 0.78 | 0.80 | $5.28B | $5.29B |
| Oct 22, 2025 | -- | 0.71 | 0.75 | $4.97B | $5.07B |
| Jul 23, 2025 | -- | 0.73 | 0.75 | $4.89B | $5.06B |
| Apr 23, 2025 | -- | 0.67 | 0.75 | $4.57B | $4.66B |
| Feb 5, 2025 | -- | 0.66 | 0.70 | $4.42B | $4.56B |
| Oct 23, 2024 | -- | 0.59 | 0.63 | $4.04B | $4.21B |
| Jul 24, 2024 | -- | 0.58 | 0.62 | $4.03B | $4.12B |
| Apr 24, 2024 | -- | 0.51 | 0.56 | $3.68B | $3.86B |
| Jan 31, 2024 | -- | 0.51 | 0.55 | $3.59B | $3.73B |
| Oct 26, 2023 | -- | 0.48 | 0.50 | $3.47B | $3.53B |
| Jul 27, 2023 | -- | 0.49 | 0.53 | $3.5B | $3.6B |
| Apr 26, 2023 | -- | 0.43 | 0.47 | $3.16B | $3.39B |
| Feb 1, 2023 | -- | 0.47 | 0.45 | $3.24B | $3.24B |
Original Filings (SEC)
10-Q2026-08-03 ↗
8-K2026-07-29 ↗
8-K2026-07-27 ↗
8-K2026-05-18 ↗
8-K2026-05-18 ↗
8-K2026-05-05 ↗
8-K2026-04-22 ↗
8-K2026-03-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
